Microtubule Disassembly and Inhibition of Mitosis by a Novel Synthetic Pharmacophore

Research output: Contribution to journalArticle

4 Citations (Scopus)


Microtubule drugs, which block cell cycle progression through mitosis, have seen widespread use in cancer chemotherapies. Although microtubules are subject to regulation by signal transduction mechanisms, their pharmacological modulation has so far relied on compounds that bind to the tubulin subunit. A new microtubule pharmacophore, diphenyleneiodonium, causing disassembly of the microtubule cytoskeleton is described here. Although this synthetic compound does not affect the assembly state of purified microtubules, it profoundly suppresses microtubule assembly in vivo, causes paclitaxel-stabilized microtubules to cluster around the centrosomes, and selectively disassembles dynamic microtubules. Similar to other microtubule drugs, this new pharmacophore blocks mitotic spindle assembly and mitotic cell division.
Original languageEnglish
Pages (from-to)102-114
JournalJournal of Cellular Biochemistry
Issue number1
Publication statusPublished - 2006

Fingerprint Dive into the research topics of 'Microtubule Disassembly and Inhibition of Mitosis by a Novel Synthetic Pharmacophore'. Together they form a unique fingerprint.

Cite this